22. Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho., P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M., Bernard, C. C. (2004). The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7, 736-44. 23. Fontoura, P., Ho, P. P., DeVoss, J., Zheng, B., Lee, B. J., Kidd, B. A., Garren, H., Sobel, R. A., Robinson, W. H., Tessier-Lavigne, M., Steinman, L. (2004). Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis. J. Immunol. 173, 6981-92. 24. Zheng, B.*, Atwal, J.*, Ho, C., Case, L., He, X. L., Garcia, K. C., Steward, O., and Tessier-Lavigne, M. (2005). Genetic deletion of Nogo Receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. USA. 102, 1205-10. * Equal contributors. 25. Anderson, D. K, Beattie, M., Blesch, A., Bresnahan, J., Bunge, M., Dietrich, D., Dietz, V., Dobkin, B., Fawcett, J., Fehlings, M., Fischer, I., Grossman, R., Guest, J., Hagg, T., Hall, E. D., Houle, J., Kleitman, N., McDonald, J., Murray, M., Privat, A., Reier, P., Steeves, J., Steward, O., Tetzlaff, W., Tuszynski, M. H., Waxman, S. G., Whittemore, S., Wolpaw, J., Young, W., Zheng, B. (2005). Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord 43, 453-8.
PRESENTATIONS AND LECTURESZheng, B., Rymond, B. C., Roy, J., and Woolford, J. L. (1994). Yeast core snRNP structure. The RNA processing meeting of the RNA Society, Madison, Wisconsin. Zheng, B. (1998). An efficient system for chromosome engineering in mice. The 10th Annual Graduate Student Symposium, Baylor College of Medicine, Houston, Texas. Zheng, B., Mills, A. A., Jurecic, V., and Bradley, A. (1998). An efficient system for chromosome engineering in mice. Meeting on Conditional Genetic Technologies in the Mouse, Cold Spring Harbor, New York. Zheng, B., Sun, Z. S., Larkin, D. W., Patrick, J. W., Lee, C. C., Bradley, A. (1998). Functional analysis of mouse mPer1 and mPer2 in circadian rhythms by gene targeting. Meeting on Mouse Molecular Genetics, Cold Spring Harbor, New York. Zheng, B. (2000). Large scale genome manipulation. The Croucher Foundation Advanced Study Institute, the University of Hong Kong, Hong Kong. Zheng, B. (2000). Manipulating the mouse genome: single gene knockouts and large chromosomal rearrangements. Department of Genetics and Genetic Engineering, Fudan University, Shanghai, China. Zheng, B., Steward, O., and Tessier-Lavigne, M. (2002). Genetic analysis of Nogo in adult spinal regeneration. International Spinal Research Trust Annual Meeting, London, United Kingdom. Zheng, B., Gonzales, R., Keirstead, H., Steward, O., and Tessier-Lavigne, M. (2002). Genetic analysis of Nogo function in adult spinal regeneration. Meeting on Axon Guidance and Neural Plasticity, Cold Spring Harbor, New York. Zheng, B., Ho, C., Keirstead, H., Steward, O., and Tessier-Lavigne, M. (2003). Genetic analysis of Nogo and Nogo-66 Receptor function in adult spinal regeneration. EMBO Workshop on the Assembly of Neural Circuits, Varenna, Italy. Zheng, B. (2005). The role of Nogo in CST regeneration failure: what are the mouse models telling us? California Spinal Cord Injury / Neural Regeneration Consortium, Roman Reed Research Meeting, Irvine, California. Zheng, B. (2005). The role of inhibitory molecules in CNS axon regeneration failure: insights from mouse models. International Spinal Research Trust Annual Meeting, London, United Kingdom. Zheng, B. (2005). Axon regeneration in the mammalian CNS: insights from mouse models. Merck neurosciences seminar, University of California, San Diego. Zheng, B. (2006). Myelin inhibitors in CNS axon regeneration - functional redundancy and an initial application of a genetic tracer. California Spinal Cord Injury / Neural Regeneration Consortium, Roman Reed Research Meeting, Irvine, California. PATENTS Bradley, A., Ramirez-Solis, R., Liu, P., Su, H., and Zheng, B. Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints. United States Patent No. 6,077,667. (June 20, 2000). (责任编辑:泉水) |